Expert consensus on laboratory standardized technical specifications for monitoring minimal residual disease using next-generation sequencing in multiple myeloma(2021).
10.3760/cma.j.issn.0253-2727.2021.12.002
- Collective Name:Laboratory Diagnosis Group, Chinese Society of Hematology, Chinese Medical Association;Plasma Cell Disease Group, Chinese Society of Hematology, Chinese Medical Association
- Publication Type:Journal Article
- MeSH:
Consensus;
Flow Cytometry;
High-Throughput Nucleotide Sequencing;
Humans;
Laboratories;
Multiple Myeloma/genetics*;
Neoplasm, Residual
- From:
Chinese Journal of Hematology
2021;42(12):974-977
- CountryChina
- Language:Chinese
